Ads
-
Related paper
- The Dynamics of THE levels OF PROLACTINE, ESTRADIOLE and TESTOSTERONE at THE women with schizophrenia and schizoAFFECTIVE frustration DURING THE therapy USING ATYPICAL ANTIPSYCHOTICAL DRUGS
- Dynamics of Psychopathological Disorders in Patients with Paranoid Schizophrenia during Atypical Antipsychotic Drugs Therapy
- DYNAMICS OF INDICATORS OF SOCIAL FUNCTIONING IN CASE OF METABOLIC SYNDROME IN PATIENTS WITH PARANOID SCHIZOPHRENIA ON THE BACKGROUND OF ATYPICAL NEUROLEPTIC AGENTS APPLICA-TION AND IMPROVEMENT OF COMORBIDITY
- Erythrocyte Aggregability Enables the Distinction between Negative and Depressive Symptoms among Schizophrenia and Schizoaffective Disorder Patients
- Substance Use in Schizophrenia: Efficacy of Atypical Antipsychotics
- Effectiveness and Tolerability (with focus on metabolic effects) of three atypical Antipsychotics in the treatment of schizophrenia- A 48 week observational study.
- SERUM TESTOSTERONE LEVELS AND ITS IMPACT ON DIABETIC PATIENTS
- The role of metformin hydrochloride in complex therapy of disorders of carbohydrate metabolism in patients with paranoid schizophrenia treated with atypical antipsychotics
- Changes in Male Testosterone Levels over the Last Century As Reflected In Facial Width-Height Ratios
- SERUM TESTOSTERONE LEVEL AS A PREDICTOR OF DRUG-INDUCED QT INTERVAL PROLONGATION AND POLYMORPHOUS VENTRICULAR TACHYCARDIA IN MALE PATIENTS TAKING CLASS III ANTIARRHYTHMIC DRUGS